Developing a Rhodococcus equi Vaccine for Foals
The goal of this study is to develop a new oral, inactivated vaccine to protect foals against pneumonia caused by Rhodococcus equi. The study is innovative in that it will entail a new, proprietary application of an established technology to produce the inactivated vaccine. The study will also further understanding of immune responses of newborn foals.
Dr. Noah D. Cohen, Texas A&M University